Meningitis — an inflammation of the protective membranes surrounding the brain and spinal cord — continues to kill hundreds of thousands of people each year and leaves many survivors with permanent disabilities including hearing loss, brain damage, and neurological impairments. Caused by bacterial, viral, or fungal infections, bacterial meningitis is the deadliest form, with symptoms that can spiral from headache and fever to confusion, seizures, and death within hours.
The disease hits hardest in the so-called “meningitis belt” stretching across sub-Saharan Africa’s Sahel region, from Senegal to Ethiopia. Before widespread vaccination, the area suffered periodic epidemics infecting hundreds of thousands, with death rates reaching 10–15% even with treatment. The MenAfriVac conjugate vaccine, rolled out in 2010, slashed serogroup A outbreaks, but other serogroups — including W, X, and C — still cause significant disease. Globally, roughly 250,000 cases and 230,000 deaths occur each year, with South Asia and parts of the Middle East also carrying heavy burdens.
Against that backdrop, the World Health Organization held two regional workshops in Copenhagen and Cairo to push countries past the planning stage and into action on the Defeating Meningitis by 2030 roadmap.
Copenhagen focused on surveillance and laboratory systems — the infrastructure that detects outbreaks early enough to mount a response and generates the data vaccine policymakers need. Cairo took a different tack, asking countries to put their national meningitis plans under the microscope, flag gaps, and set concrete priorities for the months ahead.
Countries arrived with vastly different epidemic profiles and health systems, but the fault lines turned out to matter less than expected. Immunization, lab capacity, updated clinical guidelines, care for survivors with long-term complications, and community engagement emerged as shared priorities across the board. Brazil, Colombia, El Salvador, and the United Kingdom walked through their own experiences, and other delegates picked up practical lessons they could adapt at home.
Antoine Durupt, who coordinates WHO’s Defeating Meningitis by 2030 road map, said the cross-country exchange was the point. “When countries share knowledge, learn from one another and work together across WHO regions and partners, they build stronger meningitis programmes that save lives, reduce disability and bring us closer to the goal of defeating meningitis by 2030,” he said.
Whether the momentum holds will depend on whether WHO and its partners follow through on the ground. The agency has signaled plans to set up regional communities of practice, dispatch targeted technical help, and circulate tools that countries can actually use — not just more guidance documents.
Source: WHO News Release
